HD
57
2
EQT
57
-2
ADT
53
3
XRAY
28
2
IPG
56
3
VMC
57
4
HP
48
3
PFG
45
3
MAS
58
2
EXC
53
-3
DRI
53
5
ADBE
49
3
AMG
54
2
MA
64
7
SE
61
-4
VFC
53
5
SO
53
-4
DG
6
2
WAT
55
2
SWK
64
5
HD
57
2
EQT
57
-2
ADT
53
3
XRAY
28
2
IPG
56
3
VMC
57
4
HP
48
3
PFG
45
3
MAS
58
2
EXC
53
-3
DRI
53
5
ADBE
49
3
AMG
54
2
MA
64
7
SE
61
-4
VFC
53
5
SO
53
-4
DG
6
2
WAT
55
2
SWK
64
5
Financhill
Back

Madrigal Pharmaceuticals 10K Form

Buy
64

MDGL
Madrigal Pharmaceuticals

Last Price:
347.27
Seasonality Move:
43.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDGL News And Ratings

See the #1 stock for the next 7 days that we like better than MDGL

MDGL Financial Statistics

Sales & Book Value

Annual Sales: $150K
Cash Flow: $-67.76M
Price / Cash Flow: 0
Annual Sales: $35.64
Price / Book: 9.75

Profitability

EPS (TTM): -25.12000
Net Income (TTM): $-518.67M
Gross Margin: $0
Return on Equity: -89.04%
Return on Assets: -62.74%

Madrigal Pharmaceuticals Earnings Forecast

Key Madrigal Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for MDGL have been equal to 7,786.67% of Gross Profit Margin.
  • The Interest Expense is -3.40% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 8 years.

Madrigal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MDGL
CUSIP: 558868
Website: madrigalpharma.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 5.98
Quick Ratio: 5.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MDGL Technical Analysis vs Fundamental Analysis

Buy
64
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy or a Sell?